Sunspirit Aromatherapy Head Lice Solution

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:

Eucalyptus fruticetorum,Lavandula angustifolia,Melaleuca alternifolia,Pelargonium graveolens,Rosmarinus officinalis,Sassafras albidum

Available from:

Integria Healthcare Australia Pty Ltd

Class:

Medicine Listed

Patient Information leaflet

                                ZANTAC
®
INJECTION
1
ZANTAC
® INJECTION
_ranitidine hydrochloride _
CONSUMER MEDICINE INFORMATION
ABOUT YOUR ZANTAC
INJECTION
READ ALL OF THIS LEAFLET CAREFULLY
BEFORE YOU ARE GIVEN YOUR MEDICINE
BY A DOCTOR OR NURSE.
This leaflet does not have the
complete information available about
your medicine. If you have any
questions about your medicine, you
should ask your doctor or pharmacist
(also known as chemist).
All medicines have some risks.
Sometimes new risks are found even
when a medicine has been used for
many years.
If there is anything you do not
understand, ask your doctor or
pharmacist . If you want more
information, ask your doctor or
pharmacist.
WHAT IS IN MY ZANTAC
INJECTION?
The medicine in your Zantac
injection is called ranitidine (as
hydrochloride). This belongs to a
group of medicines called H2-
antagonists.
WHAT DOES MY ZANTAC
INJECTION DO?
Zantac injection is used to stop ulcers
bleeding and other conditions caused
by too much acid in the stomach.
Zantac works by reducing the
amount of acid in the stomach. This
reduces the pain and also allows the
ulcer and reflux to heal.
BEFORE YOU HAVE A
ZANTAC INJECTION?
_DO NOT TAKE IF: _
You must not take Zantac if:
•
you have ever had an allergic
(hypersensitive) reaction to
ranitidine or any of the
ingredients listed towards the end
of this leaflet.
•
the expiry date (EXP) printed on
the pack has passed
•
the packaging is torn or shows
signs of tampering
_TELL YOUR DOCTOR IF _
You must tell your doctor if:
•
you are allergic to foods, dyes,
preservatives or any other
medicines
•
you have ever had an allergic
(hypersensitive) reaction to
ranitidine or any of the
ingredients listed towards the end
of this leaflet.
•
you are allergic to any medicine,
•
you have stomach cancer
•
you have kidney disease
•
you have heart disease,
•
you have had stomach ulcers
before and you are taking Non-
Steroidal Anti-Inflammatory
(NSAID) medicines.
•
you have a disease known as
acute porphyria.
•
you are over 65 years of age.
•
you have lung dise
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                Zantac ranitidine (as hydrochloride) PI
Page 1 of 10
AUSTRALIAN PRODUCT INFORMATION
ZANTAC
RANITIDINE (AS HYDROCHLORIDE)
TABLETS, DISPERSIBLE TABLETS, EFFERVESCENT TABLETS, ORAL LIQUID AND
INJECTION
1.
NAME OF THE MEDICINE:
Ranitidine hydrochloride.
2. AND 3. QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL
FORM
Zantac 150 mg tablets are white film-coated tablets engraved “RAN
150” on one face and plain on the other.
The tablets contain 150 mg ranitidine (as hydrochloride).
Zantac 300 mg tablets are white capsule-shaped, film-coated tablets
engraved “RAN 300” on one face and
plain on the other. The tablets contain 300 mg ranitidine (as
hydrochloride).
Zantac 150 mg dispersible tablets are white, capsule-shaped,
film-coated tablets with a breakline on one
face. The tablets contain 150 mg ranitidine (as hydrochloride). These
tablets also contain saccharin sodium
as an excipient.
Zantac 150 mg effervescent tablets are white to pale yellow, round,
bevelled tablets debossed “GS LHK” on
one side and flat on the other. The tablets contain 150 mg of
ranitidine (as hydrochloride). Each 150 mg
tablet contains 328 mg (14.3 mEq) sodium, as well as aspartame and
sodium benzoate as excipients.
Zantac 300 mg effervescent tablets are white to pale yellow, round,
bevelled tablets debossed “GS MJG” on
one side and flat on the other. The tablets contain 300 mg of
ranitidine (as hydrochloride). Each 300 mg
tablet contains 479 mg (20.8 mEq) sodium, as well as aspartame and
sodium benzoate as excipients.
Zantac oral liquid is a clear pale yellow liquid containing 150 mg
ranitidine (as hydrochloride) in each 10 mL.
It
also
contains
butyl
hydrozybenzoate,
propyl
hydroxybenzoate,
ethanol
and
saccharin
sodium
as
excipients.
Zantac injection is a clear colourless to pale yellow liquid,
practically free from visible particles containing
50 mg ranitidine (as hydrochloride) in 2 mL ampoules.
For the full list of excipients, see Section 6.1 List of excipients.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
1.
Sh
                                
                                Read the complete document